Circulating Tumor Cells and Metabolic Parameters in NSCLC Patients Treated with Checkpoint Inhibitors

Circulating tumor cells (CTC) count and characterization have been associated with poor prognosis in recent studies. Our aim was to examine CTC count and its association with metabolic parameters and clinical outcomes in non-small cell lung carcinoma (NSCLC) patients treated with immune checkpoint i...

Descripción completa

Detalles Bibliográficos
Autores principales: Castello, Angelo, Carbone, Francesco Giuseppe, Rossi, Sabrina, Monterisi, Simona, Federico, Davide, Toschi, Luca, Lopci, Egesta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072667/
https://www.ncbi.nlm.nih.gov/pubmed/32092983
http://dx.doi.org/10.3390/cancers12020487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072667/
https://www.ncbi.nlm.nih.gov/pubmed/32092983
http://dx.doi.org/10.3390/cancers12020487

Ejemplares similares